Substantia nigra echomorphology and motor cortex excitability

NeuroImage

Volumn 50, Issue 4, 2010, Pages 1351-1356

  Todd, G ^a   Taylor, J L ^b,c   Baumann, D ^d   Butler, J E ^b,c   Duma, S R ^b,c   Hayes, M ^e   Carew Jones, F ^b   Piguet, O ^b,c   Behnke, S ^f   Ridding, M C ^g   Berg, D ^d   Double, K L ^b,c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e Department of Microbiology and Infectious Diseases   (Australia)

^f SAARLAND UNIVERSITY   (Germany)

^g UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Motor cortex; Substantia nigra; Transcranial magnetic stimulation; Ultrasound

Indexed keywords

ACTION POTENTIAL; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EVOKED MUSCLE RESPONSE; FEMALE; HEALTH STATUS; HEMISPHERE; HUMAN; LEISURE; MALE; MOTOR CORTEX; NERVE EXCITABILITY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSCRANIAL MAGNETIC STIMULATION;

AGED; AGED, 80 AND OVER; EVOKED POTENTIALS, MOTOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MOTOR CORTEX; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SKELETAL; NEURAL INHIBITION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SUBSTANTIA NIGRA; TRANSCRANIAL MAGNETIC STIMULATION; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77950689675     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.01.088     Document Type: Article

References (42)

1. Awenowicz P.W., and Porter L.L. Local application of dopamine inhibits pyramidal tract neuron activity in the rodent motor cortex. J. Neurophysiol. 88 (2002) 3439-3451
2. Bares M., Kanovsky P., Klajblova H., and Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur. J. Neurol. 10 (2003) 385-389
3. Behnke S., Double K.L., Duma S., Broe G.A., Guenther V., Becker G., and Halliday G.M. Substantia nigra echomorphology in the healthy very old: correlation with motor slowing. Neuroimage 34 (2007) 1054-1059
4. Behnke S., Schroeder U., Dillmann U., Buchholz H.G., Schreckenberger M., Fuss G., Reith W., Berg D., and Krick C.M. Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET. Neuroimage 47 (2009) 1237-1243
5. Benton A.L., and Hamsher K. Multilingual Aphasia Examination (1983), AJA Associates, Iowa City
6. Berg D. Ultrasound in the (premotor) diagnosis of Parkinson's disease. Parkinsonism Relat Disord 13 Suppl. 3 (2007) S429-S433
7. Berg D., Becker G., Zeiler B., Tucha O., Hofmann E., Preier M., Benz P., Jost W., Reiners K., and Lange K.W. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53 (1999) 1026-1031
8. Berg D., Siefker C., Ruprecht-Dorfler P., and Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56 (2001) 13-17
9. Berg D., Roggendorf W., Schroder U., Klein R., Tatschner T., Benz P., Tucha O., Preier M., Lange K.W., Reiners K., Gerlach M., and Becker G. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch. Neurol. 59 (2002) 999-1005
10. Berg D., Merz B., Reiners K., Naumann M., and Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease. Mov. Disord. 20 (2005) 383-385
11. Berg D., Godau J., and Walter U. Transcranial sonography in movement disorders. Lancet Neurol. 7 (2008) 1044-1055
12. Camicioli R.M., Hanstock C.C., Bouchard T.P., Gee M., Fisher N.J., and Martin W.R. Magnetic resonance spectroscopic evidence for presupplementary motor area neuronal dysfunction in Parkinson's disease. Mov. Disord. 22 (2007) 382-386
13. Cantello R. Applications of transcranial magnetic stimulation in movement disorders. J. Clin. Neurophysiol. 19 (2002) 272-293
14. Cantello R., Tarletti R., and Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res. Brain Res. Rev. 38 (2002) 309-327
15. Doepp F., Plotkin M., Siegel L., Kivi A., Gruber D., Lobsien E., Kupsch A., and Schreiber S.J. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor. Mov. Disord. 23 (2008) 405-410
16. Duma, S.R., Piguet, O., Broe, G.A., 2007. Activation is reduced in the pre-supplementary motor area in pre-clinical Parkinson's disease. 37th Annual Meeting of the Society for Neuroscience, San Diego, USA, p. 796.799/N727.
17. Fearnley J.M., and Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (1991) 2283-2301
18. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., and Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc. Natl. Acad. Sci. USA 86 (1989) 9015-9019
19. Grigsby J., and Kaye K. Alphanumeric sequencing and cognitive impairment among elderly persons. Percept. Mot. Skills 80 (1995) 732-734
20. Hanajima R., Ugawa Y., Terao Y., Ogata K., and Kanazawa I. Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders. J. Neurol. Sci. 140 (1996) 109-116
21. Henderson J.M., Carpenter K., Cartwright H., and Halliday G.M. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications. Brain 123 (2000) 1410-1421
22. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55 (1992) 181-184
23. Ikoma K., Mano Y., and Takayanagi T. Pulsed magnetic stimulation and F waves in Parkinson's disease. Intern. Med. 33 (1994) 77-81
24. Kleine B.U., Praamstra P., Stegeman D.F., and Zwarts M.J. Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulation. Exp. Brain Res. 138 (2001) 477-483
25. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferber A., Wroe S., Asselman P., and Marsden C.D. Corticocortical inhibition in human motor cortex. J. Physiol. 471 (1993) 501-519
26. MacDonald V., and Halliday G.M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Mov. Disord. 17 (2002) 1166-1173
27. Oliviero A., Profice P., Tonali P.A., Pilato F., Saturno E., Dileone M., Ranieri F., and Di Lazzaro V. Effects of aging on motor cortex excitability. Neurosci. Res. 55 (2006) 74-77
28. Orth M., and Rothwell J.C. The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin. Neurophysiol. 115 (2004) 1076-1082
29. Peinemann A., Lehner C., Conrad B., and Siebner H.R. Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex. Neurosci. Lett. 313 (2001) 33-36
30. Priori A., Berardelli A., Inghilleri M., Accornero N., and Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 117 (1994) 317-323
31. Ridding M.C., Inzelberg R., and Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann. Neurol. 37 (1995) 181-188
32. Ruprecht-Dorfler P., Berg D., Tucha O., Benz P., Meier-Meitinger M., Alders G.L., Lange K.W., and Becker G. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage 18 (2003) 416-422
33. Ruprecht-Dorfler P., Klotz P., Becker G., and Berg D. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat. Disord. 13 (2007) 362-364
34. Spiegel J., Hellwig D., Mollers M.O., Behnke S., Jost W., Fassbender K., Samnick S., Dillmann U., Becker G., and Kirsch C.M. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain 129 (2006) 1188-1193
35. Taylor J.L., Allen G.M., Butler J.E., and Gandevia S.C. Supraspinal fatigue during intermittent maximal voluntary contractions of the human elbow flexors. J. Appl. Physiol. 89 (2000) 305-313
36. Tsai C.F., Wu R.M., Huang Y.W., Chen L.L., Yip P.K., and Jeng J.S. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism. J. Neurol. 254 (2007) 501-507
37. Utter A.A., and Basso M.A. The basal ganglia: an overview of circuits and function. Neurosci. Biobehav. Rev. 32 (2008) 333-342
38. Wechsler D. Wechsler Adult Intelligence Scale - Revised (1981), Psychological Corporation, New York
39. Wechsler D. Wechsler Memory Scale - Revised (1987), Psychological Corporation, New York
40. Wu L., Goto Y., Taniwaki T., Kinukawa N., and Tobimatsu S. Different patterns of excitation and inhibition of the small hand and forearm muscles from magnetic brain stimulation in humans. Clin. Neurophysiol. 113 (2002) 1286-1294
41. Ziemann U. TMS and drugs. Clin. Neurophysiol. 115 (2004) 1717-1729
42. Ziemann U., Tergau F., Bruns D., Baudewig J., and Paulus W. Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs. Electroencephalogr. Clin. Neurophysiol. 105 (1997) 430-437